Abivax

Latest

Abivax share with price jump: News from Evotec partner on COVID-19 drug ABX464

At Euronext Paris, the Abivax share gains significantly today. The share price of the biotech company is currently up around…

Read More »
Latest

Abivax is advancing potential COVID-19 drug ABX464

The French biotech company Abivax is preparing for a possible commercialization of its drug candidate ABX464. “Further development of ABX464…

Read More »
Latest

Abivax: 15 million euros in new funds

Abivax has agreed on loan financing totaling 15 million euros with the investor Kreos Personal-Financial.com. In addition, there is an…

Read More »
Latest

Abivax share clearly in the plus – the reasons

At Euronext Paris, more than 7 percent price gain is currently recorded for the Abivax share, which is quoted at…

Read More »
Latest

Abivax extends corona research to Brazil

Abivax can extend a Phase IIb / III trial in Corona to Brazil. The authorities there have given the green…

Read More »
Latest

Abivax receives loan from France

On the day on which CureVac receives 300 million euros from the German state through a capital increase, Abivax also…

Read More »
Back to top button
Close
Close